Preventing Dementia with a Popular Weight-Loss Drug 

Dementia affects more than 55 million individuals globally. 

Scientists are working hard to develop treatments or preventative measures ...

...for this mind-robbing disorder since it has a significant impact on society and the economy. 

The new weight-loss injection Wegovy is one of the options being investigated.

Obesity and type 2 diabetes are also significant risk factors for acquiring dementia, 

even though age is by far the highest risk factor. 

Here's where Wegovy and Ozempic, its sibling drug, come into play.

The active ingredient of both Wegovy and Ozempic, two medications used to treat type 2 diabetes, is semaglutide.

Top 7 facts about private signs zodiac